Mark Hernandez, MD
Internal Medicine · Pinecrest, FLNPI 1881679421
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Johnson & Johnson at 45.1% of the total. Reporting peaked in 2020 at $1,074 and has fallen 93.1% since, to $74 in 2025.
Across 48 payments — averaging $51.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Smith+Nephew$1K
- Getinge USA Sales, LLC$71
- Pfizer$52
- GT Metabolic Solutions Inc$47
- Melinta Therapeutics, LLC$35
- plus $39 from 2 others
Across 16 payments — averaging $6145.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$89K
- Avanir Pharmaceuticals, Inc.$10K
What the payments were for
- Food & beverage$2,479100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 15 | $1,118 |
| Smith+Nephew | 25 | $1,117 |
| Getinge USA Sales, LLC | 1 | $71 |
| Pfizer | 3 | $52 |
| GT Metabolic Solutions Inc | 1 | $47 |
| Melinta Therapeutics, LLC | 1 | $35 |
| Abbott | 1 | $22 |
| Alkermes, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Monarch Platform$649
- XARELTO$105
How this compares
$2,479 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate | 12 | $124 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Pinecrest
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.